Liu et al. found a rather anti-hypertrophic effect of miR-19a/b-3p in Ang II-induced cardiac hypertrophy by directly targeting phosphodiesterase 5A (PDE5A) [122]. The gene discussed is AGT; the disease is cardiac hypertrophy.